BCL2 and esophageal squamous cell carcinoma: In addition, Zhang et al. designed a multifunctional self-assembling nanoparticle platform based on carboxymethyl chitosan facilitating the simultaneous delivery of auristatin and siRNA targeting two genes associated with multidrug resistance in esophageal squamous cell carcinoma, i.e., MVP and BCL2.